Jane Street’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-14,334
Closed -$1.33M 11467
2021
Q4
$1.33M Buy
14,334
+9,329
+186% +$615K ﹤0.01% 5332
2021
Q3
$298K Sell
5,005
-4,714
-49% -$278K ﹤0.01% 8196
2021
Q2
$663K Sell
9,719
-9,646
-50% -$629K ﹤0.01% 6702
2021
Q1
$1.34M Buy
19,365
+1,765
+10% +$136K ﹤0.01% 4845
2020
Q4
$1.35M Sell
17,600
-56,493
-76% -$4.23M ﹤0.01% 4181
2020
Q3
$5.54M Buy
74,093
+69,504
+1,515% +$4.63M ﹤0.01% 1738
2020
Q2
$288K Sell
4,589
-6,461
-58% -$355K ﹤0.01% 5902
2020
Q1
$464K Buy
11,050
+5,381
+95% +$247K ﹤0.01% 3694
2019
Q4
$257K Sell
5,669
-495
-8% -$23.4K ﹤0.01% 4467
2019
Q3
$282K Sell
6,164
-2,891
-32% -$163K ﹤0.01% 4246
2019
Q2
$531K Buy
9,055
+366
+4% +$18.9K ﹤0.01% 3515
2019
Q1
$390K Sell
8,689
-42,763
-83% -$1.96M ﹤0.01% 3972
2018
Q4
$2M Buy
51,452
+36,434
+243% +$1.43M ﹤0.01% 1730
2018
Q3
$691K Buy
+15,018
New +$609K ﹤0.01% 3219
2018
Q2
Sell
-31,277
Closed -$1.24M 5842
2018
Q1
$1.24M Buy
+31,277
New +$1.22M ﹤0.01% 2402
2016
Q1
Sell
-3,064
Closed -$58K 4811
2015
Q4
$58K Buy
+3,064
New +$62.5K ﹤0.01% 3858
2015
Q2
Sell
-4,396
Closed -$191K 4192
2015
Q1
$192K Buy
4,396
+2,456
+127% +$114K ﹤0.01% 2905
2014
Q4
$67K Sell
1,940
-3,073
-61% -$125K ﹤0.01% 2365
2014
Q3
$210K Buy
5,013
+1,549
+45% +$69.2K ﹤0.01% 2195
2014
Q2
$203K Buy
+3,464
New +$218K ﹤0.01% 2196
2014
Q1
Sell
-1,273
Closed -$74K 3179
2013
Q4
$74K Sell
1,273
-4,193
-77% -$219K ﹤0.01% 2213
2013
Q3
$288K Sell
5,466
-19,935
-78% -$1.34M ﹤0.01% 2130
2013
Q2
$1.96M Buy
+25,401
New +$2.07M 0.03% 471

Jane Street's ARNA Position: Q1 2022 in Review

Jane Street sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 14,334 shares — an estimated $1.33M sold.

Jane Street first reported a position in ARNA in Q2 2013 and held it in 23 quarters. The position peaked at $5.54M in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Jane Street reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Jane Street sold 14,334 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.33M.
  • Jane Street first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 23 quarters.
  • Jane Street's Arena Pharmaceuticals Inc position peaked at $5.54M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.